At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jul 30, 2026 at 16:57 ET
Three AtriCure insiders sold a total of $1.42M in open-market shares over the past week, representing just 0.075% of the $1.9B market cap. The sales follow the company's strong Q2 2026 earnings beat and raised guidance reported 11 days ago. The small size relative to market cap suggests routine profit-taking rather than a bearish signal.
- Director Sven Wehrwein sold 25,000 shares at $37.84 for $946K on 2026-07-28.
- Chief Mktg & Strategy Officer Justin Noznesky sold 6,182 shares at $38.80 for $240K on 2026-07-29.
- Chief Scientific Officer Vinayak Doraiswamy sold 6,000 shares at $38.88 for $233K on 2026-07-28.
- CEO Michael Carrel made non-cash gifts of 4,700 shares on 2026-07-30 (no economic impact).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access